All View

Product Information
Registration Number BR-955
Generic Name Varicella Virus Vaccine, Live
Brand Name Varivax
Dosage Strength 1350 PFU/0.5 mL
Dosage Form Lyophilized Powder For Solution for Injection (SC)
Classification Prescription Drug (RX)
Packaging Vaccine in Borosilicate USP/ Ph Eur Type I glass vial w/ butyl chlorobutyl stopper, capped w/ aluminum seal & plastic cap w/ sterile diluent in a separate vial (Box of 1's or 10's)
Pharmacologic Category Vaccine
Manufacturer Merck Sharp & Dohme Corp.
Country of Origin United States of America
Trader
Importer Merck Sharp & Dohme (I.A.) Corporation
Distributor
Application Type Renewal
Issuance Date 28 June 2024
Expiry Date 14 July 2029